West Virginia School of Osteopathic Medicine

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, West Virginia School of Osteopathic Medicine sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).

6 total trials 1 currently recruiting 3 completed upper quartile by trial count

West Virginia School of Osteopathic Medicine: 6 sponsored US clinical trials, 1 recruiting.

West Virginia School of Osteopathic Medicine sponsors 6 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 3 completed. The most-studied condition in this pipeline is Hyperlipidemias, with 1 trials.

Upper-quartile sponsor footprint

West Virginia School of Osteopathic Medicine sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

What is open in the West Virginia School of Osteopathic Medicine pipeline

1 recruiting of 6 indexed (17% open); 3 completed (50%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Hyperlipidemias (1 trial), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

West Virginia School of Osteopathic Medicine: open-pipeline peers nationwide

Peers matched on 6 registered trials and 17% open enrollment, not the therapeutic-area sidebar.

West Virginia School of Osteopathic Medicine sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 468101214 0%20%40%60%80% Total trials Recruiting share West Virginia School of Osteopathic Medicine23andMeAardvark TherapeuticsAbbisko Therapeutics CoAbGenomics B.V Taiwan BranchAdageneAgendiaAkamis BioAngiodynamics
West Virginia School of Osteopathic Medicine sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

West Virginia School of Osteopathic Medicine sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 6 trials (± recruiting share)

Sponsors near 17% open enrollment (± trial volume)

What to do with this West Virginia School of Osteopathic Medicine page

6 registered trials is a research-attention snapshot, not an endorsement of West Virginia School of Osteopathic Medicine or any single study.

  • 1 of West Virginia School of Osteopathic Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Hyperlipidemias is the condition West Virginia School of Osteopathic Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hyperlipidemias trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

West Virginia School of Osteopathic Medicine pipeline card: 6 registered trials from official public datasets.Report a data error.